NO/redox disequilibrium in the failing heart and cardiovascular system

Journal of Clinical Investigation

Volumn 115, Issue 3, 2005, Pages 509-517

  Hare, Joshua M ^a   Stamler, Jonathan S ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

CELL DAMAGE; ENZYME SPECIFICITY; HEART FAILURE; HOMEOSTASIS; HUMAN; MOLECULAR INTERACTION; NONHUMAN; OXIDATION REDUCTION REACTION; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CARDIAC OUTPUT, LOW; CARDIOVASCULAR AGENTS; CARDIOVASCULAR SYSTEM; HUMANS; MYOCARDIUM; NITRIC OXIDE; OXIDATION-REDUCTION; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 14644423890     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200524459     Document Type: Review

References (100)

1. McCord, J.M., and Fridovitch, I. 1968. The reduction of cytochrome c by milk xanthine oxidase. J. Biol. Chem. 243:5753-5760.
2. McCord, J.M., and Fridovitch, I. 1969. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244:6049-6055.
3. Keith, M., et al. 1998. Increased oxidative stress in patients with congestive heart failure. J. Am. Coll. Cardiol. 31:1352-1356.
4. Cesselli, D., et al. 2001. Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ. Res. 89:279-286.
5. Dhalla, A.K., Hill, M.F., and Singal, P.K. 1996. Role of oxidative stress in transition of hypertrophy to heart failure. J. Am. Coll. Cardiol. 28:506-514.
6. Vanderheyden, M., et al. 2004. Hernodynamic effects of inducible nitric oxide synthase and nitrotyrosine generation in heart failure. J. Heart Lung Transplant. 23:723-728.
7. Cappola, T.P., et al. 2001. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation. 104:2407-2411.
8. Palmer, R.M.J., Ferrige, A.G., and Moncada, S. 1987. Nitric-oxide release accounts for the biological-activity of endothelium-derived relaxing factor. Nature. 327:524-526.
9. Ignarro, L.J., Buga, G.M., Wood, K.S., Byrns, R.E., and Chaudhuri, G. 1987. Endothelium-derived relaxing factor produced and released from artery and vein is nitric-oxide. Proc. Natl. Acad. Sci. U. S. A. 84:9265-9269.
10. Stamler, J.S., Singel, D.J., and Loscalzo, J. 1992. Biochemistry of nitric-oxide and its redox-activated forms. Science. 258:1898-1902.
11. Sundaresan, M., Yu, Z.X., Ferrans, V.J., Irani, K., and Finkel, T. 1995. Requirement for generation of H2O2 for platelet-derived growth-factor signal-transduction. Science. 270:296-299.
12. Irani, K., et al. 1997. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science. 275:1649-1652.
13. Forman, H.J., Fukuco, J.M., and Torres, M. 2004. Redox signaling: thiol chemistry defines which reactive oxygen and nitrogen species can act as second messengers. Am. J. Physiol. Cell Physiol. 287:C246-C256.
14. Stamler, J.S. 1994. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell. 78:931-936.
15. Wink, D.A., et al. 1997. Superoxide modulates the oxidation and nitrosation of thiols by nitric oxide-derived reactive intermediates. J. Biol. Chem. 272:11147-11151.
16. Reiter, C.D., Teng, R.J., and Beckman, J.S. 2000. Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite. J Biol. Chem. 275:32460-32466.
17. Xu, L., Eu, J.P., Meissner, G., and Stamler, J.S. 1998. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science. 279:234-237.
18. 2 sensor and NO signaling functions. Cell. 102:499-509.
19. Jia, L., Bonaventura, C., Bonaventura J., and Stamler, J.S. 1996. S-nitrosohaemoglobin: A dynamic activity of blood involved in vascular control. Nature. 380:221-226.
20. Hess, D.T., Matsumoto, A., Kim, S.O., Marshall, H., and Stamler, J.S. 2004. Protein S-nitrosylation: purview and parameters. Nat. Rev. Mol. Cell. Biol. 6:150-166.
21. Abu-Soud, H., Rousseau, D.L., and Stuehr, D.J. 2005. Nitric oxide binding to the heme of neuronal nitric-oxide synthase links its activity to changes in oxygen tension. J. Biol. Chem. 271:32515-32518.
22. Khan, S.A., et al. 2004. Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling. Proc. Natl. Acad. Sci. U. S. A. 101:15944-15948.
23. Siwik, D.A., et al. 1999. Inhibition of copper-zinc superoxide dismutase induces cell growth, hypertrophic phenotype, and apoptosis in neonatal rat cardiac myocytes in vitro. Circ. Res. 85:147-153.
24. + channels. Circ. Res. 76:325-334.
25. Thomas, J.A., Poland, B., and Honzatko, R. 1995. Protein sulfhydryls and their role in the antioxidant function of protein S-thiolation. Arch. Biochem. Biophys. 319:1-9.
26. Stamler, J.S., Lamas, S., and Fang, F.C. 2001. Nitrosylation. the prototypic redox-based signaling mechanism. Cell. 106:675-683.
27. Gow, A.J., Buerk, D.G., and Ischiropoulos, H. 1997. A novel reaction mechanism for the formation of S-nitrosothiol in vivo. J. Biol. Chem. 272:2841-2845.
28. Jaffrey, S.R., Erdjument-Bromage, H., Ferris, C.D., Tempst, P., and Snyder, S.H. 2001. Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat. Cell Biol. 3:193-197.
29. Gow, A.J., et al. 2002. Basal and stimulated protein S-nitrosylation in multiple cell types and tissues. J. Biol. Chem. 277:9637-9640.
30. Rhee, K.Y., Erdjument-Bromage, H., Tempst, P., and Nathan, C. 2005. S-nitroso proteome of Mycobacterium tuberculosis: enzymes of intermediary metabolism and antioxidant defense. Proc. Natl. Acad. Sci. U. S. A. 102:467-472.
31. Liu, L., et al. 2004. Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock. Cell. 116:617-628.
32. Xu, K.Y., Huso, D.L., Dawson, T., Bredt, D.S., and Becker, L.C. 1999. NO synthase in cardiac sarcoplasmic reticulum. Proc. Natl. Acad. Sci. U. S. A. 96:657-662.
33. Barouch, L.A., et al. 2002. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature. 416:337-340.
34. Khan, S.A., et al. 2003. Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases. Circ. Res. 92:1322-1329.
35. Stamler, J.S., and Hausladen, A. 1998. Oxidative modifications in nitrosative stress. Nat. Struct. Biol. 5:247-249.
36. Kwon, J., et al. 2004. Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors. Proc. Natl. Acad. Sci. U. S. A. 101:16419-16424.
37. Eu, J.P., et al. 2003. Concerted regulation of skeletal muscle contractility by oxygen tension and endogenous nitric oxide. Proc. Natl. Acad. Sci. U. S. A. 100:15229-15234.
38. Berry, C. E., and Hare, J.M. 2004. Xanthine oxidoreductase in the cardiovascular system: molecular mechanisms and pathophysiologic implications. J. Physiol. 555:589-606.
39. Griendling, K.K., Sorescu, D., and Ushio-Fukai, M. 2000. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86:494-501.
40. Landmesser, U., et al. 2003. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J. Clin. Invest. 111:1201-1209. doi:10.1172/JCI200314172.
41. Kuzkaya, N., Weissmann, N., Harrison, D.G., and Dikalov, S. 2003. Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols - implications for uncoupling endothelial nitric-oxide synthase. J. Biol. Chem. 278:22546-22554.
42. Ide, T., et al. 1999. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ. Res. 85:357-363.
43. Balagopalakrishna, C., Manoharan, P.T., Abugo, O.O., and Rifkind, J.M. 1996. Production of superoxide from hemoglobin-bound oxygen under hypoxic conditions. Biochemistry. 35:6393-6398.
44. Misra, H.P., and Fridovitch, I. 1972. The generation of superoxide radical during the autoxidation of hemoglobin. J. Biol. Chem. 247:6960-6962.
45. Saavedra, W.F., et al. 2002. Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart. Circ. Res. 90:297-304.
46. Landmesser, U., et al. 2002. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure - role of xanthine-oxidase and extracellular superoxide dismutase. Circulation. 106:3073-3078.
47. McCord, J.M. 1985. Oxygen-derived free radicals in postischemic tissue injury. N. Eng. J. Med. 312:159-163.
48. Saugstad, O.D. 1996. Role of xanthine oxidase and its inhibitor in hypoxia: reoxygenation injury. Pediatrics. 98:103-107.
49. Webb, A., et al. 2004. Reduction of nitrite to nitric oxide during ischemia, protects against myocardial ischemia-reperfusion damage. Proc. Natl. Acad. Sci. U. S. A. 101:13683-13688.
50. Heymes, C., et al. 2003. Increased myocardial NADPH oxidase activity in human heart failure. J. Am. Coll. Cardiol. 41:2164-2171.
51. Duilio, C., et al. 2001. Neutrophils are primary source of O2 radicals during reperfusion after prolonged myocardial ischemia. Am. J. Physiol. Heart Circ. Physiol. 280:H2649-H2657.
52. McNally, J.S., et al. 2003. Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am. J. Physiol. Heart Circ. Physiol. 285:H2290-H2297.
53. Maytin, M., et al. 2004. Pressure overload-induced myocardial hypertrophy in mice does not require gp91(phox). Circulation. 109:1168-1171.
54. Sanders, S.A., Eisenthal, R., and Harrison, R. 1997. NADH oxidase activity of human xanthine oxidoreductase generation of superoxide anion. Eur. J. Biochem. 245:541-548.
55. Zhang, Z., et al. 1998. A reappraisal of xanthine dehydrogenase and oxidase in hypoxic reperfusion injury: the role of NADH as an electron donor. Free Radic. Res. 28:151-164.
56. Cote, C.G., Yu, F.S., Zulueta, J.J., Vosatka, R.J., and Hassoun, P.M. 1996. Regulation of intracellular xanthine oxidase by endothelial-derived nitric oxide. Am. J. Physiol. Lung Cell. Mol. Physiol. 15:L869-L874.
57. Hassoun, P.M., Yu, F.S., Zulueta, J.J., White, A.C., and Lanzillo, J.J. 1995. Effect of nitric oxide and cell redox status on the regulation of endothelial cell xanthine dehydrogenase. Am. J. Physiol. 268:L809-L817.
58. Shinyashiki, M., Pan, C.J.G., Lopez, B.E., and Fukuto, J.M. 2004. Inhibition of the yeast metal reductase heme protein Fre1 by nitric oxide (NO): A model for inhibition of NADPH oxidase by NO. Free Radic. Biol. Med. 37:713-723.
59. Clancy, R.M., Leszczynskapiziak, J., and Abramson, S.B. 1992. Nitric-oxide, an endothelial-cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J. Clin. Invest. 90:1116-1121.
60. Michel, T., and Feron, O. 1997. Nitric oxide synthases: Which, where, how and why? J. Clin. Infest. 100:2146-2152.
61. Wink, D.A., and Mitchell, J.B. 1998. Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic. Biol. Med. 25:434-456.
62. Schmidt, H.H.H.W., and Walter, U. 1994. NO at work. Cell. 78:919-925.
63. Hare, J.M. 2003. Nitric oxide and excitation-contraction coupling. J. Mol. Cell. Cardiol. 35:719-729.
64. Layland, J., Li, J.M., and Shah, A.M. 2002. Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes. J. Physiol. 540:457-467.
65. Senzaki, H., et al. 2001. Cardiac phosphodiesterase 5 (cGMP-specific) modulates beta-adrenergic signaling in vivo and is down-regulated in heart failure. FASEB J. 15:1718-1726.
66. Sun, J., Xin, C., Eu, J.P., Stamler, J.S., and Meissner, G. 2001. Cysteine-3635 is responsible for skeletal muscle ryanodine receptor modulation by NO. Proc. Natl. Acad. Sci. U. S. A. 98:11158-11162.
67. Paolocci, N., et al. 2000. cGMP-independent inotropic effect of nitric oxide and peroxynitrite donors: Potential role for S-nitrosylation. Am. J. Physiol. 279:H1982-H1988.
68. Bolotina, V.M., Najibi, S., Palacino, J.J., Pagano, P.J., and Cohen, R.A. 1994. Nitric-oxide directly activates calcium-dependent potassium channels in vascular smooth-muscle. Nature. 368:850-853.
69. Foster, M.W., McMahon, T.J., and Stamler, J.S. 2003. S-nitrosylation in health and disease. Trends Mol. Med. 9:160-168.
70. Foster, M.W., Pawloski, J.R., Singel, D., and Stamler, J.S. 2005. Role of circulating S-nitrosothiols in control of blood pressure. Hypertension. 45:15-17.
71. Scharfstein, J.S., et al. 1994. In vivo transfer of nitric oxide between a plasma protein-bound resevoir and low molecular weight thiols. J. Clin. Invest. 94:1432-1439.
72. Stamler, J.S., et al. 1992. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc. Natl. Acad. Sci. U. S. A. 89:7674-7677.
73. Lipton, A.J., et al. 2001. S-nitrosothiols signal the ventilatory response to hypoxia. Nature. 413:171-174.
74. Liu, L., et al. 2001. A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature. 410:490-494.
75. Singel, D.J., and Stamler, J.S. 2005. Chemical physiology of blood flow regulation by red blood cells: The role of nitric oxide and S-nitrosohemoglobin. Annu. Rev. Physiol. 67:99-145.
76. Singel, D.J., and Stamler, J.S. 2004. Blood traffic control. Nature. 430:297.
77. McMahon, T.J., et al. 2002. Nitric oxide in the human respiratory cycle. Nat. Med. 8:711-717.
78. Datta, B., et al. 2004. Red blood cell nitric oxide as an endocrine vasoregulator - A potential role in congestive heart failure. Circulation. 109:1339-1342.
79. Gow, A.J., and Stamler, J.S. 1998. Reactions between nitric oxide and haemoglobin under physiological conditions. Nature. 391:169-173.
80. Wallace, W.J., Houtchens, R.A., Maxwell, J.C., and Caughey, W.S. 1982. Mechanism of autoxidation for hemoglobins and myoglobins - promotion of superoxide production by protons and anions. J. Biol. Chem. 257:4966-4977.
81. Mansouri, A., and Winterhalter, K.H. 1974. Non-equivalence of chains in hemoglobin oxidation and oxygen binding. Effect of organic phosphates. Biochemistry. 13:3311-3314.
82. Taketa, F., Antholine, W.E., and Chen, J.Y. 1978. Chain nonequivalence in binding of nitric-oxide to hemoglobin. J. Biol. Chem. 253:5448-5451.
83. Vila-Petroff, M.G., Younes, A., Egan, J., Lakatta, E.G., and Sollott, S.J. 1999. Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. Circ. Res. 84:1020-1031.
84. Chesnais, J.M., Fischmeister, R., and Mery, P.F. 1999. Positive and negative inotropic effects of NO donors in atrial and ventricular fibres of the frog heart. J. Physiol. 518:449-461.
85. Feron, O., Saldana, F., Michel, J.B., and Michel, T. 1998. The endothelial nitric-oxide synthase-caveolin regulatory cycle. J. Biol. Chem. 273:3125-3128.
86. Sears, C., et al. 2003. Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling. Circ. Res. 92:e52-e59.
87. Schuh, K., Uldrijan, S., Telkamp, M., Rothlein, N., and Neyses, L. 2001. The plasmamembrane calmodulin-dependent calcium pump: a major regulator of nitric oxide synthase I. J. Cell Biol. 155:201-205.
88. Matsumoto, A., Comatas, K.E., Liu, L., and Stamler, J.S. 2003. Screening for nitric oxide-dependent protein-protein interactions. Science. 301:657-661.
89. Barouch, L.A., et al. 2003. Combined loss of cardiac neuronal and endothelial nitric oxide synthase causes premature mortality and age-associated hypertropic cardiac remodeling in mice. J. Mol. Cell. Cardiol. 35:637-644.
90. Cappola, T.P., et al. 2003. Deficiency of different nitric oxide synthase isoforms activates divergent transcriptional programs in cardiac hypertrophy. Physiol. Genomia. 14:25-34.
91. Sears, C.E., et al. 2003. Myocardial NOS1 controls the lusitropic response to β-adrenergic stimulation in vivo and in vitro [abstract]. Circulation. 108:IV-249.
92. Balligand, J.-L., et al. 1995. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J. Biol. Chem. 270:14582-14586.
93. Gyurko, R., Kuhlencordt, P., Fishman, M.C., and Huang, P.L. 2000. Modulation of mouse cardiac function in vivo by eNOS and ANP. Am. J. Physiol. Heart Circ. Physiol. 278:H971-H981.
94. Damy, T., et al. 2003. Up-regulation of cardiac nitric oxide synthase 1-derived nitric oxide after myocardial infarction in senescent rats. FASEB J. 17:1934-1936.
95. Damy, T., et al. 2004. Increased neuronal nitric oxide synthase-derived NO production in the failing human heart. Lancet. 363:1365-1367.
96. Brenman, J.E., et al. 1996. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and α1-syntrophin mediated by PDZ domains. Cell. 84:757-767.
97. Feron, O., et al. 1998. Modulation of endothelial nitric-oxide synthase-caveolin interaction in cardiac myocytes. J. Biol. Chem. 273:30249-30254.
98. Massion, P.B., Feron, O., Dessy, C., and Balligand, J.L. 2003. Nitric oxide and cardiac function - Ten years after, and continuing. Circ. Res. 93:388-398.
99. Hilenski, L.L., Clempus, R.E., Quinn, M.T., Lambeth, J.D., and Griendling, K.K. 2004. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 24:677-683.
100. Mollnau, H., et al. 2002. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ. Res. 90:E58-E65.